Product Information
LIOTHYRONINE SOD 5 MCG TAB is a generic product labeled by Biocon Pharma Inc., priced at $0.2023 per EA under NDC 70377011412. Its NADAC has been published 130 times since Apr 10, 2024.
FDA first approved this application on Feb 6, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 ug/1
Manufacturer
Biocon Pharma Inc.NDC
70377011412
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LIOTHYRONINE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA218070FDA Approved
2/6/2024
TE Code
AB
On Market Since
2/12/2024
Pharmacological Classes
Price Statistics
The NADAC for LIOTHYRONINE SOD 5 MCG TAB has been published 130 times since Apr 10, 2024, and over the history we have for it it has declined 35.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2023 per EA |
|---|---|
| All-time high | $0.3151 (Apr 10, 2024) |
| All-time low | $0.1898 (Nov 20, 2024) |
| 52-week high | $0.2578 |
| 52-week low | $0.2023 |
| Median price | $0.2334 |
| Average price | $0.2350 |
| Largest weekly change | -24.0% (Apr 17, 2024) |
| Weeks tracked | 130 |
| Tracking since | Apr 10, 2024 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Biocon Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Liothyronine sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
l-Triiodothyronine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LIOTHYRONINE SOD 5 MCG TAB?
The current National Average Drug Acquisition Cost (NADAC) for LIOTHYRONINE SOD 5 MCG TAB, manufactured by Biocon Pharma Inc., is $0.2023 per EA (NDC 70377011412), effective Sep 30, 2026.
How has the price of LIOTHYRONINE SOD 5 MCG TAB changed over time?
Over the history we have for it, the NADAC for LIOTHYRONINE SOD 5 MCG TAB has declined 35.8%. It has been tracked across 130 weekly CMS publications since Apr 10, 2024.
What are the highest and lowest recorded NADAC prices for LIOTHYRONINE SOD 5 MCG TAB?
Since Apr 10, 2024, the NADAC for LIOTHYRONINE SOD 5 MCG TAB has ranged from a low of $0.1898 (Nov 20, 2024) to a high of $0.3151 (Apr 10, 2024), with a median of $0.2334 per EA.
Are there cheaper alternatives to LIOTHYRONINE SOD 5 MCG TAB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LIOTHYRONINE SOD 5 MCG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures LIOTHYRONINE SOD 5 MCG TAB?
LIOTHYRONINE SOD 5 MCG TAB (NDC 70377011412) is labeled by Biocon Pharma Inc., and CMS classifies it as a generic product.